Two doctors have become Fellows at The Clatterbridge Cancer Centre attached to Research and Innovation to boost the Trust’s ground-breaking studies.
Dr Sana Saleem and Dr Jemma Proudfoot-Jones have been appointed as Early Phase Clinical Research Fellows, working on Clatterbridge’s pioneering cancer research programme supporting the growth in early phase and cancer vaccine studies.
Dr Saleem’s background is in haematology, and she has been working as a specialist registrar at Clatterbridge Hospital and the Royal Liverpool Hospital.
She has an extensive background in early phase trial work after spending almost two years working with the early phase team at The Christie NHS Foundation Trust, in Manchester.
She said: “I developed a passion and enthusiasm for delivering early phase trials to patients in a safe way and hope to continue with this work throughout the rest of my career.”
Dr Proudfoot-Jones has looked after patients with complications of their cancer and cancer treatment through working in many and varied medical specialties over the past five years.
Most recently, she completed her second year of internal medicine training at the Countess of Chester Hospital NHS Foundation Trust, which included acute medicine and intensive care medicine. Dr Proudfoot-Jones has experience in haemato-oncology, including a rotation at Clatterbridge in 2021.
She said: “It’s wonderful to join a dedicated team performing novel and exciting early phase research that prioritises patient wellbeing and safety. I hope that our involvement will amplify the delivery of early phase research at Clatterbridge, allowing more patients across solid tumour and haemato-oncology to be recruited to early phase trials and followed up in a multi-disciplinary early phase clinic.”
The doctors, pictured above, will help to reduce the wait time for patients joining clinical trials at Clatterbridge as they will assist in assessing their suitability for the research studies.